SERUM ÜRİK ASİT DÜZEYİNİN KARARLI KORONER ARTER HASTALIĞININ CİDDİYETİ İLE İLİŞKİSİ

Amaç: İleri yaş, diyabet, hipertansiyon, insulin direnci, hipertrigliseridemi ve metobolik sendrom gibi kardiyovasküler hastalık risk faktörlerinin yüksek serum ürik asit düzeyleri ile ilişkili olduğu bilinmektedir. Çalışmamızın amacı bilinen kararlı iskemik kalp hastalığı nedeniyle koroner anjiyografi yapılan hastalarda serum ürik asit düzeyleri ile koroner arter hastalığının yaygınlığını karşılaştırmaktır.

THE RELATIONSHIP BETWEEN SERUM URIC ACID LEVEL AND SEVERITY OF STABLE CORONARY ARTERY DISEASE

Objective: Cardiovascular disease risk factors are known to be associated with elevated serum uric acid levels. The aim of our study was to evaluate the relationship between the severity of coronary artery disease and serum uric acid levels in patients undergoing coronary angiography for known stable ischemic heart disease.

___

  • 1. Pan H, Yan D, Xu M, Li F, Ren M, Zhang J, Wu M.Interaction Between Lactate and Uric Acid is Associated With a Higher Prevalence of Metabolic Syndrome: A Community-Based Study. Exp Clin Endocrinol Diabetes. 2018 Sep 10.
  • 2. Xia X, He F, Wu X, Peng F, Huang F, Yu X. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis 2014;64(2):257-64.
  • 3. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951;34:1421-31.
  • 4. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerosis heart disease. N Engl J Med1997;337(6):408-16.
  • 5. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2018 Sep 13.
  • 6. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2010;62(2):170-80.
  • 7. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51(3):606.
  • 8. Roberto ML, Luigi PB, Victor M, Jonathan A, Anderson A, Laura E, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2016;17(4):412.
  • 9. Duran M, Kalay N, Akpek M, Orscelik O, Elcik D, Ocak A. High Levels of Serum Uric Acid predict severity of ischemic heart disease in Patients With Acute Coronary Syndrome. Angiology 2012;63(6):448-52.
  • 10. Qureshi AE, Hameed S, Noeman A. Relationship of serum uric acid level and angiographic severity of coronary artery disease in male patients with acute coronary syndrome. Pak J Med Sci 2013;29(5):1137-41.
  • 11. Xiong Z, Zhu C, Qian X, Zhu J, Wu Z, Chen L. Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and Framingham risk strati cation. J Invasive Cardiol 2011;23(12):501-4.
  • 12. Lu P, Hu D, Lu J, Wang W, Chen B. The association between uric acid and coronary heart disease. Zhonghua Nei Ke Za Zhi 2002;41(8):526-9.
  • 13. Puig JG, Martínez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 2008;20:187-91.
  • 14. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141(7):637-44.
  • 15. Ndrepepa G, Braun S, King L, Fusaro M, Tada T, Cassese S. Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest 2013;43(3):256-66.
  • 16. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005;96(4):489-95.
  • 17. Tamariz L, Agarwal S, Soliman EZ, Chamberlain AM, Prineas R, Folsom AR. Association of serum uric acid with incident atrial brillation (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011;108(9):1272-6.
  • 18. Kwon CH, Lee SH, Lee JY, Ryu S, Sung KC. Uric Acid and Risk of Atrial Fibrillation in the Korean General Population. Circ J 2018 25;82(11):2728-35.
  • 19. Noman A, Ang DS, Ogston S. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010;375:2161-7.
İstanbul Tıp Fakültesi Dergisi-Cover
  • Başlangıç: 1916
  • Yayıncı: İstanbul Üniversitesi Yayınevi
Sayıdaki Diğer Makaleler

SERÖZ ENDOMETRİAL KANSER VE UTERİN KARSİNOSARKOMDA GENEL SAĞKALIM VE HASTALIKSIZ SAĞKALIMIN KARŞILAŞTIRILMASI

Alpaslan KABAN, Samet TOPUZ, Hamdullah SOZEN, Yavuz SALİHOGLU

TÜRKİYE’DE TIBBİ EKOLOJİ VE HİDROKLİMATOLOJİ TIPTA UZMANLIK TEZLERİNİN YAYINLANMA ORANI: KESİTSEL BİR ÇALIŞMA

Sinan KARDEŞ

AÇ SIÇANLARA SKOPOLAMİN UYGULANMASI VE YEM VERİLMESİ İLE OLUŞAN KONVÜLSİYONLAR: YEM YOKSUNLUĞU SÜRESİNİN ETKİSİ

Aslı ZENGİN TÜRKMEN, Asiye NURTEN, Nurhan ENGİNAR

TÜRKİYE SOSYAL GÜVENLİK KURUMU 2010-2015 YILLARI İŞ KAZASI, MESLEK HASTALIĞI VE MORTALİTE SAYILARININ İLLERE GÖRE STANDARDİZASYONU

Osman Faruk BAYRAMLAR, Elif EZİRMİK, Halim İŞSEVER, Zeynep BAYRAMLAR

DOKSORUBİSİNİN MEME KANSERİ HÜCRELERİ İLE BİLGİSAYARLI TASARIMI

Leyla TÜRKER ŞENER, Serda KECEL GÜNDÜZ, Aziz ŞENER, Bilge BIÇAK, Yağmur KÖKCÜ, Ayşen E. ÖZEL, İşıl ALBENİZ

İLAÇ UYUMUNU BİLDİRİM ÖLÇEĞİ’NİN TÜRKÇE UYARLAMASININ GEÇERLİK VE GÜVENİRLİK ÇALIŞMASI

Esin TEMELOĞLU ŞEN, Özlem SERTEL BERK, Dilşad SİNDEL

SERUM ÜRİK ASİT DÜZEYİNİN KARARLI KORONER ARTER HASTALIĞININ CİDDİYETİ İLE İLİŞKİSİ

Samim EMET

SUPİN VE PRON POZİSYONLARDA SERİ MANYETİK REZONANS GÖRÜNTÜLEME İLE KONUS MEDULLARİS HAREKET ARALIĞININ ANALİZİ: 40 ARDIŞIK SAĞLIKLI İNSAN DENEKTE ELDE EDİLEN SONUÇLAR

Cengiz GÖMLEKSIZ, Halil CAN, Umut YAKA, Burcu GÖKER, Aydın AYDOSELI, Mehmet BARBUROĞLU, Altay SENCER, Utku ÖZGEN, Serra SENCER, Ali Güven YÖRUKOĞLU, Talat KIRIŞ

NORMAL KARYOTİPLİ PATOLOJİK ULTRASON BULGUSU OLAN FETUSLARDA MLPA (MULTİPLEX LİGATİON-DEPENDENT PROBE AMPLİFİCATİON) UYGULAMALARI

Güven TOKSOY, Birsen KARAMAN, Zehra Oya UYGUNER, Kader YILMAZ, Recep HAS, Hülya KAYSERİLİ, Peter MINY, Seher BAŞARAN

YAŞLILARDA KIRILGANLIK VE KANSER TARANMA ORANLARI

Birkan İLHAN, Oğuz Kağan BAKKALOĞLU